Stelac Advisory Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,201
Closed -$373K 156
2022
Q4
$373K Buy
2,201
+143
+7% +$25.9K 0.17% 103
2022
Q3
$385K Hold
2,058
0.18% 103
2022
Q2
$334K Buy
2,058
+1,409
+217% +$223K 0.13% 116
2022
Q1
$122K Sell
649
-992
-60% -$188K 0.04% 155
2021
Q4
$435K Buy
1,641
+611
+59% +$165K 0.12% 106
2021
Q3
$298K Buy
+1,030
New +$264K 0.08% 165

Other funds holding RGEN

Stelac Advisory Services's RGEN Position: Q1 2023 in Review

Stelac Advisory Services sold out of Repligen (RGEN) in Q1 2023, closing a stake of 2,201 shares — an estimated $373K sold.

Stelac Advisory Services first reported a position in RGEN in Q3 2021 and held it in 6 quarters. The position peaked at $435K in Q4 2021. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Stelac Advisory Services reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Stelac Advisory Services sold 2,201 Repligen shares in Q1 2023, an estimated $373K.
  • Stelac Advisory Services first reported a position in Repligen in Q3 2021 and held it in 6 quarters.
  • Stelac Advisory Services's Repligen position peaked at $435K in Q4 2021.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Stelac Advisory Services's 13F filing for Q1 2023, filed 9 May 2023.